Cite
HARVARD Citation
Bi, Y. et al. (2017). Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease. Bioorganic & medicinal chemistry letters. 27 (13), pp. 2962-2966. [Online].